Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

A new study shows how earthquake monitors can better track space junk by tuning into their sonic booms Actor Matthew McConaughey’s lawyer, Kevin Yorn, joins ABC News Live to discuss steps McConaughey ...